Jefferson Life Sciences

Jefferson Life Sciences is a venture capital firm dedicated to advancing transformative innovations in medicine. The firm invests in early-stage life sciences companies, focusing on biotechnology and medical device sectors. By combining intelligent financing with deep operational expertise, Jefferson Life Sciences helps turn bold scientific ideas into meaningful therapeutic solutions for patients in need.

The firm's investment approach is guided by four key pillars: rooted in bold ideas, true transformational potential, strong visionary teams, and practical plans for value creation. Jefferson Life Sciences seeks high-risk, high-reward propositions that aim to revolutionize patient outcomes and redefine standards of care. The firm actively partners with its portfolio companies, providing strategic expertise, operational guidance, and access to a deep network, including leading pharma executives, exceptional operators, key opinion leaders, and co-investment partners.

Jefferson Life Sciences is part of Jefferson River Capital, a family office financed by Hamilton (Tony) James, vice chairman for the Blackstone Group LP. The firm has been involved in several private equity transactions and venture capital funding rounds, including investments in Character Biosciences and Juvena Therapeutics. Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Juvena Therapeutics is a clinical-stage biotechnology company pioneering tissue restorative biologics for chronic muscle and metabolic diseases. The firm is led by Managing Partner Dr. Laura Lande-Diner, a veteran biotech entrepreneur and former President and Chief Business Officer of Satellite Bio.

Jefferson Life Sciences takes pride in its selectivity, forming long-term partnerships and focusing exclusively on ideas that have the potential to change the therapeutic landscape. The firm brings versatile investment structures and a long-term view to support companies across their full lifecycle—from early development through commercialization, in both private and public settings. By combining intelligent financing with deep operational expertise, Jefferson Life Sciences helps turn bold scientific ideas into meaningful therapeutic solutions for patients in need.